Related Experiment Video
Updated: Jun 3, 2026

09:34
Synthesis of Information-bearing Peptoids and their Sequence-directed Dynamic Covalent Self-assembly
Published on: February 6, 2020
Synthesis of a versatile peptidomimetic scaffold
S Hanessian1, G McNaughton-Smith
1Department de Chimie, Universite de Montreal, Montreal, Quebec, Canada.
Methods in Molecular Medicine
|March 8, 2011
Summary
Researchers developed a novel synthetic pathway for creating peptidomimetics, which are drug-like molecules mimicking natural peptides but with enhanced metabolic stability. This method facilitates the design of new therapeutics by rigidifying peptide structures to promote beta-turn formation.
Area of Science:
- Medicinal Chemistry
- Drug Design
- Organic Synthesis
Background:
- Natural peptides offer therapeutic potential but suffer from poor metabolic stability.
- Peptidomimetics are designed to mimic peptide structures while improving drug-like properties.
- Secondary structure mimetics, particularly those inducing beta-turns, are of significant interest.
Purpose of the Study:
- To develop a general synthetic pathway for novel peptidomimetic core structures.
- To enable the attachment of various appendages to these core units.
- To prepare a specific peptidomimetic nucleus and elaborate it into a beta-turn peptidomimetic.
Main Methods:
- Investigation of synthetic pathways for peptidomimetic core structures.
- Utilizing combinatorial techniques for appendage attachment.
- Preparation and elaboration of a novel peptidomimetic nucleus.
Main Results:
- A general synthetic route towards substituted peptidomimetic cores was established.
- A novel peptidomimetic nucleus was successfully synthesized.
- The nucleus was elaborated into a fully extended beta-turn peptidomimetic.
Conclusions:
- The developed synthetic strategy provides a versatile platform for creating metabolically stable peptidomimetics.
- This approach facilitates the design of drug candidates with improved therapeutic profiles.
- The methodology supports the generation of diverse peptidomimetic libraries for drug discovery.

